Artificial intelligence is rapidly advancing in the realm of medical diagnosis, with recent studies showing that AI models like OpenAI's o1 and ChatGPT can match or even exceed human physicians in accuracy for identifying diseases. An April 2026 analysis revealed that the o1 model achieved a 78% accuracy rate on complex diagnostic cases from the New England Journal of Medicine and outperformed experienced doctors when diagnosing actual emergency room patients. Similarly, a 2024 study found that ChatGPT independently surpassed physicians in diagnosing complex cases. While AI excels at pattern recognition and categorizing symptoms, it currently falls short in determining the best course of treatment. Diagnosis involves matching patient symptoms to established medical patterns, a task where large language models thrive. They function similarly to the mental shortcuts, known as illness scripts, that doctors use to quickly identify diseases based on historical data. However, medical management—the process of deciding how to care for a patient after a diagnosis—is far more complex. This stage requires prioritizing among multiple reasonable options based on individual circumstances, patient values, and the nuances of uncertainty. Experienced doctors rely on their understanding of the specific person in front of them to guide treatment. For instance, two 68-year-old men diagnosed with the same early-stage prostate cancer may receive radically different recommendations. One patient, who has no other health issues but struggles with anxiety regarding uncertainty, might choose immediate surgery or radiation to eliminate the tumor. The other, who suffers from advanced heart failure and prioritizes quality of life over a distant cancer risk, would likely opt for active surveillance. In both scenarios, the medical options are identical, but the human judgment required to weigh risks against personal values and immediate health threats is something AI currently cannot replicate. Medical literature and AI can present statistical outcomes, such as survival rates or the likelihood of disease progression, but they cannot account for the subjective reality of a patient's life. Guidelines are designed for an idealized average patient, whereas real-world medicine deals with unique individuals who often have histories of medical mistrust or specific risk tolerances. Doctors facilitate shared decision-making by acknowledging uncertainty and navigating these complexities alongside their patients. While AI can calculate scores for measurable risks, such as the likelihood of a heart attack based on clinical data, it cannot understand the lived experience of risk or the emotional weight of medical decisions. Consequently, while AI offers powerful diagnostic support and can quickly provide reasonable initial answers for clear-cut conditions, the critical next steps in patient care remain a human domain. The transition from knowing what ails a patient to deciding how to treat them involves a deep, empathetic conversation that considers the totality of a person's life. As AI continues to integrate into healthcare, it is poised to enhance diagnostic speed and accuracy, but the art of management, driven by clinical judgment and human connection, remains the exclusive strength of medical professionals.